Intravesical nanocrystalline silver decreases experimental bladder inflammation

被引:44
作者
Boucher, W. [1 ]
Stern, J. M. [5 ]
Kotsinyan, V. [1 ]
Kempuraj, D. [1 ]
Papaliodis, D. [1 ]
Cohen, M. S. [3 ,4 ]
Theoharides, T. C. [1 ,2 ]
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[3] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
[4] Lahey Clin Fdn, Dept Urol, Burlington, MA USA
[5] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
关键词
bladder; inflammation; cystitis; interstitial; silver; tumor necrosis factor-alpha;
D O I
10.1016/j.juro.2007.11.037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: Interstitial cystitis is a sterile bladder inflammatory disease characterized by pelvic pain, urinary urgency and frequency. Nanocrystalline silver has anti-inflammatory properties, prompting us to investigate its effect in experimental bladder inflammation. Materials and Methods: Nanocrystalline silver (0.01%, 0.05%, 0.1%, 0.5% or 1%) or phosphate buffered saline (Invitrogen (TM)) (0.5 ml) was introduced intravesically in Sprague-Dawley female rat (Charles River Laboratories, Wilmington, Massachusetts) bladders for 20 minutes, followed by vehicle or protamine sulfate (10 mg/ml for 30 minutes) and lipopolysaccharide (Sigma (R)) (2 mg/ml for 45 minutes). Urine was collected. throughout for histamine assay. The catheter was removed, the rat was returned to its cage and 4 hours later it was sacrificed. The bladder was harvested, minced and cultured overnight. The medium was collected for tumor necrosis factor-alpha assay. Results: Mean +/- SD total urine histamine increased from 270 +/- 190 ng in 4 controls to 842 +/- 239 ng after protamine sulfate/lipopolysaccharide and it decreased to 505 +/- 187 ng in 6 animals after pretreatment with 1% nanocrystalline silver (p = 0.036). Tumor necrosis factor-a release in explant medium increased from 0.02 +/- 0.03 pg/mg in 6 controls to 0.28 +/- 0.15 pg/mg in 14 animals after treatment with protamine sulfate/lipopolysaccharide and it decreased to 0.12 +/- 0.11 pg/mg in 10 animals pretreated with nanocrystalline silver (p = 0.009). Nanocrystalline silver was not effective at less than 1% and at 1% alone it released 0.05 +/- 0.07 pg/mg tumor necrosis factor-alpha in 7 rats (vs phosphate buffered saline in 6, p = 0.387). Nanocrystalline silver (1%) significantly decreased bladder inflammation and mast cell activation. These effects were apparent even 4 days later. Conclusions: Intravesical administration of nanocrystalline silver (1%) decreased urine histamine, bladder tumor necrosis factor-a and mast cell activation without any toxic effect. This action may be useful for interstitial cystitis.
引用
收藏
页码:1598 / 1602
页数:5
相关论文
共 20 条
[1]
Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis [J].
Bhol, KC ;
Schechter, PJ .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1235-1242
[2]
Mast cells mediate the severity of experimental cystitis in mice [J].
Bjorling, DE ;
Jerde, TJ ;
Zine, MJ ;
Busser, BW ;
Saban, MR ;
Saban, R .
JOURNAL OF UROLOGY, 1999, 162 (01) :231-236
[3]
Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation [J].
Boucher, W. ;
Kempuraj, D. ;
Cao, J. ;
Papaliodis, D. ;
Theoharides, T. C. .
JOURNAL OF UROLOGY, 2007, 177 (03) :1186-1190
[4]
Inflammatory cell types and clinical features of interstitial cystitis [J].
Erickson, DR ;
Belchis, DA ;
Dabbs, DJ .
JOURNAL OF UROLOGY, 1997, 158 (03) :790-793
[5]
Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis [J].
Gonzalez, RR ;
Fong, T ;
Belmar, N ;
Saban, M ;
Felsen, D ;
Te, A .
JOURNAL OF UROLOGY, 2005, 173 (02) :630-634
[6]
HANNO PM, 2007, CAMPBELLS UROLOGY, P330
[7]
Lavelle J, 2001, Urology, V57, P113, DOI 10.1016/S0090-4295(01)01047-0
[8]
EVIDENCE FOR UROTHELIAL CELL ACTIVATION IN INTERSTITIAL CYSTITIS [J].
LIEBERT, M ;
WEDEMEYER, G ;
STEIN, JA ;
WASHINGTON, R ;
FAERBER, G ;
FLINT, A ;
GROSSMAN, HB .
JOURNAL OF UROLOGY, 1993, 149 (03) :470-475
[9]
Liebert M, 1991, Semin Urol, V9, P124
[10]
Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office [J].
Rosenberg, MT ;
Hazzard, M .
JOURNAL OF UROLOGY, 2005, 174 (06) :2231-2234